Orange Book product · Generic (ANDA)
CEPHRADINE
CEPHRADINE
At a glance
May 19, 1988
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 19, 1988
38 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
CEPHRADINE
Strength
125MG/5ML
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
Not listed
Application
ANDA 062858
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CEPHRADINE
- —VELOSEF '250'Brand (NDA)
NDA 050548 · ERSANA
- —VELOSEFBrand (NDA)
NDA 050530 · BRISTOL MYERS SQUIBB
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062859 · BARR
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062850 · BARR
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062851 · BARR
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062813 · VITARINE
- 1987CEPHRADINEGeneric (ANDA)
ANDA 062762 · IVAX SUB TEVA PHARMS
- 1987CEPHRADINEGeneric (ANDA)
ANDA 062683 · TEVA
- 1987CEPHRADINEGeneric (ANDA)
ANDA 062693 · TEVA
- —ANSPORGeneric (ANDA)
ANDA 061859 · GLAXOSMITHKLINE
- —VELOSEFGeneric (ANDA)
ANDA 061764 · APOTHECON
- —ANSPORGeneric (ANDA)
ANDA 061866 · GLAXOSMITHKLINE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
